ArticleInternational journal of molecular sciences2023

β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus.

Serena Milano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.